ライフサイエンスコーパス: MFI

1 MFI for CD18 was decreased in both CD4+ and CD8+ T cells

2 MFI varied according to manufacturer, kit, bead type and

3 ning for anti-HLA antibodies using the 3,000 MFI threshold may be important in managing transplant ca

4 hout leakage (PPV, 88.1% vs 90.6% [P = .01]; MFI, 2.1 vs 2.4 [P = .007]), most markedly during the cr

5 arkers in a diverse cohort, baseline sICAM-1 MFI is associated with HCC incidence.

6 e age, antiviral treatment, and high sICAM-1 MFI; on multivariate analysis, sICAM-1 remained associat

7 The growth mechanism of silicalite-1 (MFI zeolite) is juxtaposed between classical models that

8 intercellular adhesion molecule 1 (sICAM-1) MFI.

9 suggested optimal cutoffs from 1000 to 1500 MFI.

10 ), a functional feature distinct from IL-17 (MFI = 11.07 +/- 1.22).

11 trol patients (CD62P 8.9+/-0.8 to 12.3+/-1.2 MFI, n=25, p < 0.05; CD41a 382+/-25 to 454+/-26 MFI, n=2

12 ly in recipients with DSAs greater than 2000 MFI in the second run.

13 ric 7E3 Fab (neutrophils 146+/-30 to 82+/-22 MFI, n=25, p < 0.0001; monocytes 256+/- 53 to 160+/-38 M

14 , n=25, p < 0.05; CD41a 382+/-25 to 454+/-26 MFI, n=25, p < 0.05, CD61a 436+/-52 to 529+/-58 MFI, n=1

15 , p < 0.0001; monocytes 200+/-40 to 248+/-36 MFI, n=17, p < 0.05) and decreased in the patients selec

16 p < 0.0001; monocytes 256+/- 53 to 160+/-38 MFI, n= 17, p < 0.05).

17 , n=25, p < 0.05; CD61a 398+/-32 to 410+/-38 MFI, n=7, p=NS).

18 fluorescence intensity (MFI) versus 42 +/- 4 MFI for stimulated GP IIb/IIIa expression (p < 0.001).

19 ients, an increase in nCD64 expression >/=40 MFI predicted intensive care unit (ICU)-acquired infecti

20 ter therapy (mean decrease of 1916 [SE, 425] MFI, P < 0.01).

21 1.38-3.43; P = 0.0008), DSA greater than 500 MFI at transplant (HR, 1.64; 95% CI, 1.05-2.57; P = 0.03

22 , n=25, p < 0.05, CD61a 436+/-52 to 529+/-58 MFI, n=11, p < 0.05); it did not increase in the patient

23 threshold was increased to greater than 8000 MFI, because no matches were found with standard allocat

24 meric 7E3 Fab (CD62P 13.2+/-1.0 to 9.0+/-0.9 MFI, n=25, p < 0.05; CD61a 398+/-32 to 410+/-38 MFI, n=7

25 ntibodies (sensitization) were defined by an MFI of more than 1000.

26 If the thresholds were increased to an MFI of 2000 or less and 5000 or less, an extra 6.4 and 6

27 Increasing the threshold to an MFI of 2000 or less may provide an acceptable balance fo

28 group, mean peak panel reactive antibody and MFI at transplant were 51% +/- 7% and 960 +/- 136, respe

29 etween platelets count and both of CD62P and MFI.

30 nstrate that wNMR outperformed SEC, DLS, and MFI in that it was most consistently sensitive to increa

31 y a single conformer was found (BEA, LTA and MFI).

32 Using Luminex and MFI quantification, anti-HLA antibodies are common befor

33 ine nanosheets of zeolite frameworks MWW and MFI.

34 PPV and MFI were correlated with the endothelial activation mark

35 e bis-imidazolium cation with n = 4, TON and MFI were also obtained, and again two (19)F MAS NMR reso

36 munodominant, but not the sum, of antibodies MFI.

37 3,000 (group III), and 24% had antibodies at MFI 1,000 to 3,000 (group II).

38 e cases with a posttransplant DSA peaking at MFI >2000 U on microbead assay, rejection did not occur.

39 ntensity (MFI) = 31.42 +/- 4.39 vs baseline, MFI = 12.26 +/- 1.77, p < 0.05), a functional feature di

40 Single antigen flow bead MFI thresholds allowing XM positivity to be predicted we

41 of predominantly amorphous aggregates before MFI crystallization.

42 iled consideration of the structures of both MFI, and a closely related material MEL, lead to the pro

43 ts contract upon calcination similar to bulk MFI crystals.

44 iated with AAD, but the quantity assessed by MFI levels may play a role.

45 proved all other fatigue aspects measured by MFI, including Physical Fatigue and Mental Fatigue (acup

46 CD62L MFI on PPD- and PWM-stimulated gammadelta T-cell recepto

47 rescence intensity (MFI) and decreased CD62L MFI on CD4(+) cells from infected animals.

48 CD63 MFI expression was reduced from 68 248 (29 336-92 001) t

49 verted to C1q - when diluted to a comparable MFI level as the C1q - DSA from AMR- patients, and some

50 Manganese-containing MFI-type Mn-ZSM-5 zeolite was synthesized by a facile on

51 o those of other mesoporous and conventional MFI zeolites.

52 A highly crystalline MFI zeolite structure was formed under pH = 11 in 2 days

53 ered silicate moieties and the crystallizing MFI zeolite nanosheet framework.

54 hter structures of higher framework density (MFI) under hydrothermal conditions.

55 sk of AMR is higher in patients with a dnDSA MFI level that is greater than 3,000.

56 on at 1 year was 30% in the group with dnDSA MFI level of 3,000 or greater but only 4% for the group

57 DSA MFI greater than 10 000 versus MFI 1000 to 10 000 at 1 y

58 DSA MFI values increased at the time of AAD and returned to

59 d significantly higher IgG, C1q, and C3d DSA MFI than nonrejecting or C4d-negative patients, respecti

60 m of mean fluorescence intensity of DSA (DSA MFI-Sum) of 6,000 or higher (OR, 18; 95% CI, 7.0-47; P <

61 as 2.03 (95%CI, 1.05-3.92; P = 0.04) for DSA MFI-Sum of 6,000 or higher and 2.23 (95% CI, 1.04-4.80;

62 1.73 m(2) per log10 increase in Class II DSA MFI (p < 0.01).

63 protocols based on their immunodominant DSA MFI pretransplant (D1: 100-500, D2: 501-1000, and D3: 10

64 ter evaluated through the immunodominant DSA MFI than through the sum of DSA MFI.

65 High-dose IVIG resulted in modest DSA MFI reductions in patients with previous graft damage, w

66 dominant DSA MFI than through the sum of DSA MFI.

67 red with 4 of 7 (57%) patients with peak DSA MFI 2000 to 7000U, and 2 of 12 (17%) patients with peak

68 0U, and 2 of 12 (17%) patients with peak DSA MFI less than 2000U (P<0.02).

69 Our study suggests that DSA MFI-Sum and HLA class of DSA are characteristics predict

70 on from January 2000 to April 2009, had DSA (MFI >/=1000) in serum 10 to 14 months postliver transpla

71 riable regression analysis that included DSA-MFI-Sum or HLA DSA class.

72 nts are indeed due to significantly enhanced MFI-polymer adhesion and distribution of MFI crystals.

73 th MFI structure reveals that the exfoliated MFI nanosheet is 1.5 unit cells (3.0 nm) thick and wrink

74 h other MFI membranes prepared from existing MFI materials (such as exfoliated nanosheets or nanocrys

75 for MFI >/=100 vs. 4.7[2.4-8.8], P<0.001 for MFI >/= 800).

76 from MFI 100 to 800 (1.7[0.8-3.2], P=0.1 for MFI >/=100 vs. 4.7[2.4-8.8], P<0.001 for MFI >/= 800).

77 eactivity and selectivity, also inferred for MFI from titration of OH groups by Na(+), have not been

78 rely at the pH and temperatures required for MFI synthesis.

79 The obtained OSDA-free MFI nanosheets disperse well in water and can be used fo

80 eased linearly with higher class II DSA from MFI 100 to 800 (1.7[0.8-3.2], P=0.1 for MFI >/=100 vs. 4

81 s of high-quality, mesoporous zeolite (e.g., MFI-type) nanocrystals is presented, based on a biomass-

82 Between groups, MFI trends were analyzed.

83 lites without 8-MR channels (H-BEA, H-FAU, H-MFI).

84 n the locations of exchangeable cations in H-MFI and on the monomolecular cracking and dehydrogenatio

85 g zeolites with varying channel structure (H-MFI, H-FER, H-MOR) and between OH groups within eight-me

86 tivity of alkane cracking catalysis in the H-MFI zeolite is investigated using both static and dynami

87 panol (0.075-4 kPa) was studied on zeolite H-MFI (Si/Al = 26, containing minimal amounts of extra fra

88 s follows: 66% had MFI 1000 to 4999, 14% had MFI 5000 to 10 000, and 20% had MFI greater than 10 000.

89 999, 14% had MFI 5000 to 10 000, and 20% had MFI greater than 10 000.

90 of DSA+ recipients were as follows: 66% had MFI 1000 to 4999, 14% had MFI 5000 to 10 000, and 20% ha

91 presence of anti-HLA antibodies at the high MFI threshold (>3,000) was associated with lower transpl

92 ggest that DSA-sensitized patients with high MFI levels can receive transplantation across the HLA-ba

93 DSA+ patients regardless of MFI, and higher MFI at 1 year predicts DSA persistence at 5 years.

94 C1q + DSA exhibited significantly higher MFI values regardless of whether they were from AMR+ or

95 dominant DSA (iDSA, the DSA with the highest MFI level) was 6724+/-464, and 41.6% of patients had iDS

96 IgG MFI was analyzed after elimination of prozone effect, an

97 cipients and conclude that assessment of IgG MFI may add predictive accuracy, without an independent

98 e highest accuracy was computed for peak IgG MFI (AMR, 0.73; C4d + AMR, 0.71).

99 IgGpan MFI alone showed a very strong association with standard

100 IgGpan MFI greater than 14,154 predicted standard C1q positivit

101 Combining all IgG subclass MFI and IgGpan MFI only marginally improved the prediction of standard

102 standard C1q positivity compared with IgGpan MFI alone (Deltar=0.02).

103 ssociation of AHG C1q positivity with IgGpan MFI was less strong (r=0.51).

104 ng on SAB is strongly associated with IgGpan MFI.

105 vival was detected in patients with class II MFI more than or equal to 1000 (75% vs. 91.9%, P=0.055).

106 were only evident in patients with class II MFI more than or equal to 500 (estimated glomerular filt

107 ion chromatography (SEC), microflow imaging (MFI), and dynamic light scattering (DLS), and water NMR

108 rate structure-direction effect for n = 4 in MFI, with each imidazolium ring, in two different orient

109 LF compared with blood (median difference in MFI 1337, p=0.0020) and that of CXCR2, CCR1, CCR2, and C

110 Periodic DFT calculations suggest that F in MFI resides always in the [4(1)5(2)6(2)] cages, with the

111 gely dissimilar intensities were observed in MFI.

112 ncentration of AMB to yield 90% reduction in MFI relative to growth controls, was determined for 27 c

113 fused vessels (PPV) and the mean flow index (MFI) were lower in patients with dengue with plasma than

114 tation, class I/II distribution, and initial MFI).

115 e single-line manifold micro flow injection (MFI) systems.

116 antibodies (DSA) mean florescence intensity (MFI) greater than 10 000 and requires confirmation in pa

117 Cytokine mean florescence intensity (MFI) was the primary predictor and HCC development the p

118 b is measured as mean florescence intensity (MFI).

119 el of DSA had median fluorescence intensity (MFI) >2000 U, in 6 of 10 when the microbead MFI >4000 U.

120 ears) and lower mean fluorescence intensity (MFI) (2658, 1573-3819 vs. 7820, 5166-11 990).

121 ated PBE cells (mean fluorescence intensity (MFI) = 31.42 +/- 4.39 vs baseline, MFI = 12.26 +/- 1.77,

122 d CD25 and CD44 mean fluorescence intensity (MFI) and decreased CD62L MFI on CD4(+) cells from infect

123 ) more than 100 mean fluorescence intensity (MFI) at the time of transplant is associated with a sign

124 ession of 230 median fluorescence intensity (MFI) identified sepsis with a sensitivity of 89% (81%-94

125 protein (EGFP) mean fluorescence intensity (MFI) in B-lymphoid but not T-lymphoid, myeloid, fibrobla

126 esults with the mean fluorescence intensity (MFI) in Luminex class I single antigen flow beads (SAFB)

127 s with DSA at median fluorescence intensity (MFI) more than 7000U experienced rejection, compared wit

128 munologic risk, mean fluorescence intensity (MFI) more than or equal to 100 for class I and more than

129 Mean fluorescence intensity (MFI) of 70 total DSA decreased by 12%at the end of treat

130 measured by the mean fluorescence intensity (MFI) of antibodies stored with known stabilizers.

131 nly DSAs with a mean fluorescence intensity (MFI) of greater 999 were included.

132 pulation and by mean fluorescence intensity (MFI) of the dye.

133 The dnDSA mean fluorescence intensity (MFI) of the stable function patient group (n=8; eGFR dec

134 ) increased the mean fluorescence intensity (MFI) of the transduced cells 4-fold.

135 reases in CD11a mean fluorescence intensity (MFI) on naive, central memory, and effector memory CD4+

136 Comparing median fluorescence intensity (MFI) signals for the influenza A virus and hemagglutinin

137 GR isoform.The mean fluorescence intensity (MFI) using immunofluorescence analysis for GRalpha was 4

138 A or with a DSA mean fluorescence intensity (MFI) value of 500 or less, screening by bead-based assay

139 d sera, Luminex mean fluorescence intensity (MFI) values for IgG-SAB and C1q-SAB correlated poorly (r

140 -HLA antibodies mean fluorescence intensity (MFI) values were stable prior to BTZ (P = 0.96) but decr

141 nce of AMR, DSA mean fluorescence intensity (MFI) values, and immunoglobulin G isotype was determined

142 VLA-4 mean fluorescence intensity (MFI) varied 35-fold (range, 30 to 1,110; median, 219.5).

143 and 138 +/- 19 mean fluorescence intensity (MFI) versus 42 +/- 4 MFI for stimulated GP IIb/IIIa expr

144 parallel to IgG mean fluorescence intensity (MFI), allows for improved prediction of AMR.

145 ss specificity, mean fluorescence intensity (MFI), C1q-binding, and IgG subclass, and graft injury ph

146 uantified using mean fluorescence intensity (MFI).

147 eater than 2000 mean fluorescence intensity (MFI).

148 LA antibodies at mean fluorescent intensity (MFI) greater than or equal to 3,000 (group III), and 24%

149 Peak DSA mean fluorescent intensity (MFI) levels were significantly higher at baseline (class

150 tins) and higher mean fluorescent intensity (MFI) positivity.

151 -25 to 255+/-31 mean fluorescence intensity [MFI, mean+/-SEM], n=25, p < 0.0001; monocytes 200+/-40 t

152 y 0 DSA levels (mean fluorescence intensity [MFI] > 3000) with a complement-dependent cytotoxicity-ne

153 n difference in mean fluorescence intensity [MFI] 703 arbitrary units [p=0.0699] for CXCR1 and 658.7

154 xpression (Deltamean fluorescence intensity [MFI] of 118.5 +/- 16.8), followed by CD11b(+)Gr-1(int) (

155 IgGpan results (mean fluorescence intensity [MFI]>500), strong complement-binding IgG1 and IgG3 subcl

156 [SFI]/10,000 median fluorescence intensity [MFI]) were determined to be unacceptable and entered int

157 nding strength (mean fluorescence intensity [MFI]_max).

158 l infection at the maternal-fetal interface (MFI) in the early gestational stages.

159 hannels comprising a microfluidic interface (MFI) that prevents media leakage between the two dimensi

160 by in-plane XRD, indicating well-intergrown MFI films that are strongly attached to the substrate.

161 Encapsulation into MFI via direct hydrothermal syntheses was unsuccessful b

162 ctroscopic analysis of Co(II) exchanged into MFI, it was inferred that the fraction of Co(II) (and, b

163 sentially unchanged upon transformation into MFI.

164 with the Multidimensional Fatigue Inventory (MFI).

165 approach based on the exfoliation of layered MFI, followed by centrifugation to remove non-exfoliated

166 requires confirmation in patients with lower MFI (1000-10 000).

167 High VLA-4 expression (> median MFI), compared with low expression, was associated with

168 The median MFI of the immunodominant class I or II DSA in the peak

169 Mesostructured MFI zeolite nanosheets are established to crystallize no

170 (MFI) >2000 U, in 6 of 10 when the microbead MFI >4000 U.

171 In 8 of 10 cases, the microbead MFI at the time of resolution was greater than at the on

172 ype Pg381 or isogenic major (DPG-3)-, minor (MFI)-, or double fimbriae (MFB)-deficient mutant P. ging

173 ML-MFI was first exfoliated by melt compounding and then de

174 s were prepared from a multilamellar MFI (ML-MFI) zeolite.

175 ing up to 35 wt % of solvothermally modified MFI crystals.

176 sing first year peak MFI (pMFI), eight month MFI change (DeltaMFI), and eighteen month MFI trend (MFI

177 th MFI change (DeltaMFI), and eighteen month MFI trend (MFI slope).

178 ng agents were prepared from a multilamellar MFI (ML-MFI) zeolite.

179 ced MFI-polymer adhesion and distribution of MFI crystals.

180 ted in preferentially oriented thin films of MFI, which had sub-12-nm thickness in certain cases.

181 graft survival was 96% to 100% regardless of MFI (P = NS).

182 graft failure in DSA+ patients regardless of MFI, and higher MFI at 1 year predicts DSA persistence a

183 if transplantation occurs at a threshold of MFI of 500 or less or in those without preformed DSA.

184 alculated panel-reactive antibodies based on MFI of 2000, 4000, and 8000 was unchanged in all patient

185 ibenzyl ketone and dibenzyl ketone sorbed on MFI zeolites is examined.

186 membranes that compare favourably with other MFI membranes prepared from existing MFI materials (such

187 =16; eGFR decline>25%) using first year peak MFI (pMFI), eight month MFI change (DeltaMFI), and eight

188 ctions for specimens with very low positive (MFI < 1,000) or "no-call" H1 results reliably distinguis

189 intergrowth to synthesize high-aspect-ratio MFI nanosheets with a thickness of 5 nanometres (2.5 uni

190 Global normalization further reduced MFI variation to levels near 20%.

191 ardized) operating procedure greatly reduced MFI variation from 62% to 25%.

192 These transformations required MFI seeds or organic templates for FAU parent zeolites,

193 g 39 patients with a lower immunologic risk (MFI between 500 and 3000 at day 0) who received the same

194 correlation between IgG-SAB MFI and C1q-SAB MFI was lowest using undiluted sera and SAB with greater

195 onsequently, the correlation between IgG-SAB MFI and C1q-SAB MFI was lowest using undiluted sera and

196 Prediction and sensitivity SAFB MFI thresholds were determined, respectively, assessing

197 XM results were tightly associated with SAFB MFI values.

198 own to produce high-flux and ultra-selective MFI membranes that compare favourably with other MFI mem

199 thylenediaminetetraacetic acid-treated serum MFI was considered.

200 -factor zeolite (siliceous ZSM-5, [Si96O192]-MFI) membranes is reported.

201 However, until now, single MFI nanosheets have been prepared using a multi-step app

202 Single-unit-cell Sn-MFI, with the detectable Sn uniformly distributed and ex

203 Integrating iDSA HLA class specificity, MFI level, C1q-binding status, and IgG subclasses in a C

204 perior to a model including all IgG subclass MFI (r=0.62).

205 Combining all IgG subclass MFI and IgGpan MFI only marginally improved the predicti

206 035) compared with treatment initiation (T0) MFI.

207 The MFI distribution of DSA+ recipients were as follows: 66%

208 The MFI of the immunodominant DSA (iDSA, the DSA with the hi

209 nderstanding of HCV-specific immunity at the MFI as well as novel insights into mechanisms that limit

210 and activation of innate immune cells at the MFI.

211 ditions, 200 J/m(2) of UV light enhanced the MFI 7-fold.

212 For GRbeta, the MFI was 350 +/- 60 and 1,389 +/- 143 for PBMCs and neutr

213 olecular-weight thiols and a decrease in the MFI of an oxidation-sensitive probe, dihydrofluorescein

214 sites in the zeolite HZSM-5, a member of the MFI family of zeolite structures, contradicts the tradit

215 The feasibility of the use of the MFI membranes as an explosive preconcentrator is examine

216 luable chemical intermediates, and therefore MFI-type zeolites are widely used in the chemical indust

217 Nanometre-thick MFI crystals (nanosheets) have been introduced in pillar

218 uspensions of zeolite nanosheets (3 nm thick MFI layers) were prepared in ethanol following acid trea

219 In this MFI zeolite, two distinct (19)F MAS NMR resonances with

220 dies converted to C1q + when concentrated to MFI levels comparable to those observed for AMR+/C1q + s

221 ge (DeltaMFI), and eighteen month MFI trend (MFI slope).

222 A zeolite with structure type MFI is an aluminosilicate or silicate material that has

223 on membranes containing nonporous uncalcined MFI revealed that the performance enhancements are indee

224 DSA MFI greater than 10 000 versus MFI 1000 to 10 000 at 1 year was also more likely to per

225 er but only 4% for the group with dnDSA with MFI less than 3,000.

226 For the dnDSA group with MFI of 3,000 or greater (compared with the group with MF

227 000 or greater (compared with the group with MFI<3,000), the hazard ratio for AMR was 10.6 (95% confi

228 er than 13 (P = 0.004) in DSA+ patients with MFI 1000 to 10 000.

229 y putative chronic AMR in DSA+ patients with MFI from 1000 to 10 000.

230 plication of the method to a 2D zeolite with MFI structure reveals that the exfoliated MFI nanosheet

231 lation of metal clusters (Pt, Ru, Rh) within MFI was achieved by exchanging cationic metal precursors

232 with n = 4 was able to produce also zeolite MFI at highly concentrated conditions.

233 The higher activity in zeolite MFI with pores smaller than BEA and FAU is caused by a l

234 crystal-thick b-oriented pure silica zeolite MFI films produced by in situ crystallization.

235 Highly selective thin zeolite MFI membranes are synthesized on porous stainless steel

236 organic Mg(OH)(2) nanostructures on zeolite (MFI) crystal surfaces in a controlled manner.